Dorothee Gramatzki - Concepedia

Author

Dorothee Gramatzki

Also Known As

D Gramatzki, D. Gramatzki, DOROTHEE GRAMATZKI, Dorothee Gramatzki, Dorothee Gramatzki (411005), Dorothée Gramatzki, Gramatzki, Dorothee, Joerg Felsberg, Sarah Loew

135

Publications

Citations

H-Index

Concepts

All Affiliations

University Hospital of Zurich University of Zurich Heidelberg University Heinrich Heine University Düsseldorf German Cancer Research Center

About

Dorothee Gramatzki is an author at University Hospital of Zurich specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.4K
2	Engineering	2	2	165
3	Arts	1	1	19
4	Education	1	1	13
5	Nursing	1	1	19

Dorothee Gramatzki

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups Michael Weller, Ruthild G. Weber, Edith Willscher, Acta Neuropathologica PathologyHigh-grade GliomasBrain LesionGliomaTranscriptome-wide Profiling	2015	307
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, Acta Neuropathologica Recurrent Mapk PathwayNeuro-oncologyGliomaTumor HeterogeneityPiloid Features	2018	271
Prognostic or predictive value of <i>MGMT</i> promoter methylation in gliomas depends on <i>IDH1</i> mutation Wolfgang Wick, Christoph Meisner, Bettina Hentschel, Neurology	2013	227
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i> -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich, Clinical Cancer Research	2017	173
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling Guido Reifenberger, Ruthild G. Weber, Vera Riehmer, International Journal of Cancer EngineeringMgmt Promoter MethylationPathologyHigh-grade GliomasGlioma	2014	146
Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells Dorothee Gramatzki, G. Pantazis, Jens Schittenhelm, Oncogene Signaling PathwayMedicineHuman Glioblastoma CellsCancer Cell BiologyCancer Biology	2009	122
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy Michael Weller, Kerstin Kaulich, Bettina Hentschel, International Journal of Cancer Tumor InnervationImmunologyPathologyPrognostic SignificanceHigh-grade Gliomas	2013	117
DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment Hendrik Witt, Dorothee Gramatzki, Bettina Hentschel, Neuro-Oncology	2018	110
Transforming growth factor-β pathway activity in glioblastoma Karl Frei, Dorothee Gramatzki, Isabel Tritschler, Oncotarget Neuro-oncologyGliomaGrowth FactorMedicineTgf-β Isoforms	2015	100
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study Dorothee Gramatzki, Patrick Roth, Elisabeth J. Rushing, Annals of Oncology	2018	98

Page 1